Clinithink Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 39
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $15.6M
Latest Deal Amount
  • Investors
  • 5

Clinithink General Information

Description

Developer of a cloud-based platform designed to transform the existing unstructured clinical narrative into insights and structured data. The company's technology converts unstructured clinical data from EMRs, EHRs, documents, free text fields, discharge summaries, clinical notes and other communication between care providers to structured data, enabling healthcare and life sciences organizations to collect clinical trial data using structured tools.

Contact Information

Website
www.clinithink.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Medical Records Systems
Media and Information Services (B2B)
Primary Office
  • 4 Derwen Road
  • Bridgend CF31 1LH
  • Wales, United Kingdom
+44 029 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Clinithink Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 07-Jan-2019 $15.6M 000.00 000.00 Completed Generating Revenue
6. Later Stage VC 20-Feb-2018 00.00 000.00 000.00 Completed Generating Revenue
5. Accelerator/Incubator 01-Oct-2017 000.00 Completed Generating Revenue
4. Later Stage VC 11-Jan-2017 00.00 000.00 000.00 Completed Generating Revenue
3. Early Stage VC (Series A) 30-Jun-2014 00.000 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 23-Apr-2012 $7.38M $9.3M 000.00 Completed Generating Revenue
1. Angel (individual) 12-Jan-2011 $1.92M $1.92M 00.000 Completed Startup
To view Clinithink’s complete valuation and funding history, request access »

Clinithink Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
C Preferred 0,000 00.000000 00000.00 00000.00 00 00000.00 00.000
B Preferred 000 00.000000 00000.00 00000.00 00 00000.00 0.000
B Preferred 00 00.000000 00000.00 00000.00 00 00000.00 0.00
B Preferred 000 00.000000 00000.00 00000.00 00 00000.00 0.000
B Preferred 000 00.000000 00000.00 00000.00 00 00000.00 0.000
A Preferred 000 00.000000 00000.0 00000.0 00 00000.0 0.000
B Preferred 0,000 00.000000 00000.00 00000.00 00 00000.00 00.000
Ordinary 00 00.000000 0000.00 0000.00 00 0000.00 0.000
A Preferred 2,582 $0.126597 $3429.48 $3429.48 1x $3429.48 19.83%
Ordinary 135 $0.126597 $1265.97 $1265.97 1x $1265.97 1.04%
To view Clinithink’s complete cap table history, request access »

Clinithink Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a cloud-based platform designed to transform the existing unstructured clinical narrative into insights and
Other Healthcare Technology Systems
Bridgend, United Kingdom
39 As of 2021
000.00
00.00 0000-00-00
0000000000 0 000.00

000000

it, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
0000000 0000000 0000000
San Mateo, CA
000 As of 0000
000.00
000000&0 000.00

00000000

is nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate veli
0000000000000 00000000
Creve Coeur, MO
000 As of 0000
000.00
0000 0000-00-00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Clinithink Competitors (36)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Apixio Formerly VC-backed San Mateo, CA 000 000.00 000000&0 000.00
000000000 Venture Capital-Backed Creve Coeur, MO 000 000.00 0000000000 0 000.00
0000 0 00 Venture Capital-Backed Pasadena, CA 00 0000 000000 - 000 0000
0000 00000 Venture Capital-Backed Newton, MA 00 000.00 00000000000 000.00
0000 000000 Private Equity-Backed Alpharetta, GA 0000 00000 000000000000 00000
You’re viewing 5 of 36 competitors. Get the full list »

Clinithink Patents

  • 5

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Clinithink Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2012235939-A1 Real-time automated interpretation of clinical narratives Granted 25-Mar-2011 000000000 0
CA-2831354-A1 Real-time automated interpretation of clinical narratives Pending 25-Mar-2011 000000000
AU-2012235939-B2 Real-time automated interpretation of clinical narratives Active 25-Mar-2011 000000000
US-20120278102-A1 Real-time automated interpretation of clinical narratives Abandoned 25-Mar-2011 000000000 00
EP-2689390-A1 Real-time automated interpretation of clinical narratives Ceased 25-Mar-2011 G06Q10/10
To view Clinithink’s complete patent history, request access »

Clinithink Executive Team (9)

Name Title Board Seat Contact Info
Christopher Tackaberry MD Co-Founder, Chief Executive Officer & Board Member
Martin Deleay Chief Financial Officer
Marc Goldman Chief Operating Officer
Phil Davies Chief Information Officer
Peter Johnson MD Research and Development Director
You’re viewing 5 of 9 executive team members. Get the full list »

Clinithink Board Members (8)

Name Representing Role Since
Barbara Bierer MD Self Board Member 000 0000
Christopher Tackaberry MD Clinithink Co-Founder, Chief Executive Officer & Board Member 000 0000
Conor Green TT Capital Partners Board Member 000 0000
Ernest Keet Vanguard Atlantic Board Member 000 0000
Melanie Goward Ph.D Development Bank of Wales Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Clinithink Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Clinithink Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Merck Global Health Innovation Fund Corporate Venture Capital Minority 000 0000 000000 0
TT Capital Partners Growth/Expansion Minority 000 0000 000000 0
G4A Accelerator/Incubator Minority 000 0000 000000 0
Development Bank of Wales Venture Capital Minority 000 0000 000000 0
Vanguard Atlantic Venture Capital Minority 000 0000 000000 0
To view Clinithink’s complete investors history, request access »

Ready to get started?

Request a free trial